Platelet Rich Plasma

DB19295ApprovedInvestigationalWithdrawnProtein Based Therapies

Platelet Rich Plasma: Overview.

Mechanism: Pharmacologically active on Epidermal growth factor receptor, TGF-beta receptor type-2, and Vascular endothelial growth factor receptor
Curator reviewed
Also known as: AUTOLOGOUS CONDITIONED PLASMA · AUTOLOGOUS PLATELET RICH PLASMA · Autologous platelet-rich plasma · autologous PRP · Leukocyte-poor platelet rich plasma

Resolves to

Compound

Targets

What you can answer from here — as of July 16, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

424Clinical trialsPhase, status and sponsor resolved per trial

14+ReferencesStructured and connected to the statements they support

Which drugs share a target with Platelet Rich Plasma, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.